Group Exercise in Cancer Patients Under Active Treatment: Feasibility Pilot Study.

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

About this trial

The aim of this study to investigate the feasibility in hospital reality, of a group exercise program for oncology patients under active treatment and evaluate its impact on some outcomes considered relevant from both clinical and subjective point of view.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

neoplastic tumor

age>= 18

prognosis> 12 months

ECOG <=2

Disqualifiers

sensory deficits who cannot perform physical exercise

cognitive impairment that compromises collaboration and questionnaire filling

patients with pathologies (e.g. neurological, psychiatric) that do not allow the obtaining of valid informed consent

Trial design

Design model

Parallel

Treatments tested in this trial

  • exercise programme for group with ECOG 0-1

    Procedure/Surgery

    exercise programme for group with ECOG 2

  • exercise programme for ECOG 2 group

    Procedure/Surgery

    this intervention shall be proportionated to the ECOG status of the group

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: ECOG 0-1Experimental treatment 1 intervention
Group B: ECOG 2Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

adherence to the group exercise programme

overall adherence to the group exercise programme \> 40%

Time frame
through study completion, an average of 2 years
2

Frequency

The frequency of at least 70% of the exercise sessions foreseen by the programme.

Time frame
through study completion, an average of 2 years

Secondary outcomes

1

QoL

Questionnaire in which patients have to describe quality of life during study treatment

Time frame
through study completion, an average of 2 years
2

tolerance to effort

The effect of the EFG program on mood tone and physical function

Time frame
through study completion, an average of 2 years

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: